Adline Chem Lab

Adline Chem Lab Net Debt per Share

Delisted·Sep 16, 2026

The Net Debt per Share of Adline Chem Lab (524604.BO) as of Nov 6, 2026 is 2.17 INR. In the previous year, Net Debt per Share was 2.17 INR — a change of 0.12% (higher).

Net Debt per Share

2.17INR

YoY

0.12%

Last updated:

Net Debt per Share of Adline Chem Lab is 2023 2.17 INR. Net Debt per Share of Adline Chem Lab was 2022 2.17 INR. It decreases by 0.12% higher compared to the previous year.

The Adline Chem Lab Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2021
4.54 INR
Jan 1, 2022
2.17 INR
Jan 1, 2023
2.17 INR
The Adline Chem Lab Net Debt per Share history
YEARNet Debt per ShareYoY
2.17INR+0.12%
2.17INR-52.24%
4.54INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Adline Chem Lab Stock analysis

What does Adline Chem Lab do? Adline Chem Lab Ltd. manufactures pharmaceutical products for domestic and international markets. The company's domestic product lines include anti-infectives, bone health, gastroenterology care, hemostatic, multi-vitamins, pediatric care, pain and inflammation, pregnancy and reproductive care, respiratory care, and hepatocare. For international markets, the firm offers tablets, capsules, and injections. Veterinary products such as B Complex Liver Extract With Vitamin B12 Inection, Chlorpheniramine Injection IP, Triflupromazine Hydrochloride Injection IP, Triamcinolone Acctonide Injection IP, Triamcinolone Acetonide IP, and Tetracyclin-bolus Tablets are sold to veterinary clients. Educational supplements like Demo-Dose Dyaz, Demo-dose colac, Demo-Dose Dilat, and Demo-Eose eryth target healthcare professionals for product demonstration purposes. The domestic market segments purchase pharmaceuticals for human health needs, while international buyers acquire tablets, capsules, and injections for global distribution. Veterinary clients specifically buy the listed veterinary products for animal health applications. Educational supplements are purchased by healthcare professionals to demonstrate product efficacy during training sessions. Adline Chem Lab Ltd. generates revenue through the sale of pharmaceutical products to domestic consumers, international distributors, veterinary practices, and healthcare professionals. The company's domestic market focuses on human health solutions, while international sales emphasize standardized dosage forms. Veterinary product sales cater to animal health sectors, and educational supplements support product education within the medical community. Adline Chem Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Adline Chem Lab stock

Net Debt per Share of Adline Chem Lab is 2.17 INR in 2023.

Net Debt per Share of Adline Chem Lab changed from 2.17 INR to 2.17 INR, representing a 0.12% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share Adline Chem Lab since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Adline Chem Lab

All Key Metrics — Adline Chem Lab